Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term

Department of Obstetrics and Gynaecology, University of Berne, Inselspital G3-855 KKL, CH-3010 Berne, Switzerland. nick.bersinger@dkf2.unibe.ch

OBJECTIVE: Pre-eclampsia is a placental disease of unknown cause. Maternal circulating concentrations of a number of protein markers are altered (mainly increased) in pre-eclampsia in comparison with controls of matched gestational age. Inhibin A and activin A were found to be elevated even before the onset of the disease. The aim of this study was to compare the levels of inhibin A, activin A: follistatin ratio, leptin, pregnancy-associated plasma protein-A (PAPP-A), human placental lactogen (HPL), placenta growth factor (PLGF) and pregnancy-specific beta1-glycoprotein (SP1) in placental extracts of normal pregnant women and pre-eclampsia patients at term. METHODS: Placental tissue from normal pregnancies (n=14) and patients with pre-eclampsia (n=13) were collected at term (> or =37 weeks of gestation) and stored at -80 degrees C. The frozen tissue pieces were homogenised and the above-mentioned proteins were measured by specific enzyme-linked immunosorbent assays. RESULTS: Placental contents of inhibin A and PAPP-A were significantly higher (P<0.05) in pre-eclampsia placental extracts compared with the controls. Activin A:follistatin ratio was higher (23) in pre-eclampsia extracts than in the controls (15). Leptin, PLGF, SP1 and HPL levels were not altered in the term pre-eclampsia placenta. Inhibin A and PAPP-A contents were increased in the placental extracts of pre-eclampsia patients. CONCLUSION: Our data suggest that the placenta, possibly by a compensatory mechanism, is at least in part responsible for the altered serum levels observed in pre-eclampsia.

This article has been cited by other articles:

				H. Nishizawa, K. Pryor-Koishi, M. Suzuki, T. Kato, H. Kogo, T. Sekiya, H. Kurahashi, and Y. Udagawa Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients Mol. Hum. Reprod., October 1, 2008; 14(10): 595 - 602. [Abstract] [Full Text] [PDF]

				H. Laivuori, M.J. Gallaher, L. Collura, W.R. Crombleholme, N. Markovic, A. Rajakumar, C.A. Hubel, J.M. Roberts, and R.W. Powers Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia Mol. Hum. Reprod., September 1, 2006; 12(9): 551 - 556. [Abstract] [Full Text] [PDF]

				C. Molinari, E. Grossini, D. A. S. G. Mary, F. Ribichini, N. Surico, and G. Vacca The role of nitric oxide in the peripheral vasoconstriction caused by human placental lactogen in anaesthetized pigs Exp Physiol, May 1, 2006; 91(3): 603 - 610. [Abstract] [Full Text] [PDF]

				D. S. Tannetta, S. Muttukrishna, N. P. Groome, C. W. G. Redman, and I. L. Sargent Endothelial Cells and Peripheral Blood Mononuclear Cells Are a Potential Source of Extraplacental Activin A in Preeclampsia J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5995 - 6001. [Abstract] [Full Text] [PDF]

				D. Casagrandi, C. Bearfield, J. Geary, C.W. Redman, and S. Muttukrishna Inhibin, activin, follistatin, activin receptors and {beta}-glycan gene expression in the placental tissue of patients with pre-eclampsia Mol. Hum. Reprod., April 1, 2003; 9(4): 199 - 203. [Abstract] [Full Text] [PDF]